Benninger, Felix

Afawi, Zaid

Korczyn, Amos D

Oliver, Karen L

Pendziwiat, Manuela

Masayuki, Nakamura

Sano, Akira

Helbig, Ingo

Berkovic, Samuel F

Blatt, Ilan

2016-04

OBJECTIVE: The aim of the study was to characterize the clinical features of nine patients in three families with chorea-acanthocytosis (ChAc) sharing the same rare c.2343del mutation in the VPS13A gene. METHODS: Genetic test results, clinical description, magnetic resonance imaging (MRI), and electroencephalography (EEG), as well as laboratory results are summarized. RESULTS: ChAc is a rare genetic disorder characterized by hyperkinetic movements, seizures, cognitive decline, neuropsychiatric symptoms, and acanthocytes on peripheral blood smear. This unique cohort of nine patients is characterized by seizures as a first and prominent symptom. In our patients, other features of ChAc appeared later, including tics, other movement disorders, dysarthria, and mild to moderate cognitive decline. SIGNIFICANCE: Patients with chorea-acanthocytosis carrying the described rare mutation can present with focal, treatment-resistant seizures.

Epilepsia 2016; 57(4): 549-556

Epilepsia

0000-0002-1121-9513

0000-0003-4580-841X

https://ahro.austin.org.au/austinjspui/handle/1/16196

Chorea-acanthocytosis

Chorein

Epilepsy

Genetics

VPS13A

Seizures as presenting and prominent symptom in chorea-acanthocytosis with c.2343del VPS13A gene mutation

Journal Article